Karan Julka, MD
Pulmonary Disease · Castro Valley
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 5
- 2 carriers
- Offices
- 5
Offices
5 locations · Inpatient Specialists of California PC · Sutter Bay Medical Foundation
Hospitals listed: Eden Medical Center. That is not proof they admit you there this week.
Plans that list them
5 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Julka’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
5 of 5 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Eden Medical CenterCastro Valley, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.122, Oct 2024 – Sep 2025
See every measure and the patient survey for Eden Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.122 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.89) · 819 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.46 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 137.41 (92.94 to 181.88) · 70 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 78 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.1 · 207 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 355 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 1,714 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 4,697 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.1 to 0.5) · 4,676 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.69 (0.53 to 4.85) · 860 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.56 (0 to 3.24) · 251 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.75 (1.17 to 4.32) · 818 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.76 (0 to 15.78) · 261 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.09 (2.08 to 10.1) · 242 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.64 (0.16 to 3.12) · 233 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.85) · 4,132 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 60 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.431 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.292 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.307 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.61 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 258 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 22.6 · 225 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 2.4 · 367 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 390 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 58 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 88 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.6 to 17.4) · 68 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 205 cases | No different | Jan 2024 – Dec 2024 |
What patients said (431 patients answered, 17% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$95,374
Medicare paid this office $95,374 for 568 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 232 | $23,935 | $76 |
| Return visit (30+ min) | 136 | $18,609 | $106 |
| New patient visit (45+ min) | 81 | $10,694 | $132 |
| Critical care, first 30-74 minutes | 38 | $9,891 | $177 |
| Test to measure expiratory airflow and volume | 167 | $4,535 | $26 |
See all 16 services
| Short return visit (20+ min) | 232 | $23,935 | $76 |
| Return visit (30+ min) | 136 | $18,609 | $106 |
| New patient visit (45+ min) | 81 | $10,694 | $132 |
| Critical care, first 30-74 minutes | 38 | $9,891 | $177 |
| Test to measure expiratory airflow and volume | 167 | $4,535 | $26 |
| New patient visit (30+ min) | 41 | $3,349 | $82 |
| New patient visit (60+ min) | 16 | $2,929 | $183 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 15 | $2,637 | $176 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $2,007 | $67 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 30 | $1,810 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,707 | $100 |
| Short return visit | 28 | $1,512 | $50 |
| Biopsy of lung airway using an endoscope | 14 | $728 | $52 |
| Test for exercise-induced lung stress | 19 | $624 | $31 |
| Evaluation of use of breathing device | 17 | $269 | $16 |
| Exam of lung airways using an endoscope | 12 | $1 | $0 |
Who their Medicare patients are
568 Original Medicare patients in 2024. Average age 74 · Under 65 10% · 85 and older 11% · Women 54% · Also on Medicaid 36% · Health risk score 1.79. At or below the middle of the specialty; the typical pulmonary disease clinician is at 2.13.
Conditions among them: High blood pressure 75% · COPD 46% · Diabetes 36% · Coronary heart disease 33% · Heart failure 28% · Chronic kidney disease 28% · Atrial fibrillation 27% · Cancer 24% · Depression 22% · Stroke 11% · Dementia 9%.
The office billed $476,234, Medicare allowed $127,924 and paid $95,374; for 1,167 services of 42 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 568 | 1,167 | 74 | 1.79 | $476,234 | $95,374 |
| 2023 | 609 | 1,350 | 73 | 2.00 | $539,670 | $122,787 |
| 2022 | 612 | 1,510 | 73 | 1.93 | $570,151 | $135,380 |
| 2021 | 556 | 1,506 | 72 | 2.17 | $619,420 | $154,695 |
| 2020 | 635 | 1,482 | 72 | 2.30 | $443,934 | $124,204 |
| 2019 | 782 | 2,140 | 72 | 1.94 | $459,306 | $149,369 |
| 2018 | 847 | 2,509 | 71 | 2.08 | $537,500 | $183,249 |
| 2017 | 921 | 2,656 | 71 | 2.03 | $583,810 | $196,873 |
| 2016 | 937 | 2,509 | 72 | 2.12 | $536,687 | $182,671 |
| 2015 | 950 | 2,563 | 71 | 2.17 | $486,835 | $186,116 |
| 2014 | 915 | 2,683 | 71 | 1.98 | $468,584 | $181,396 |
| 2013 | 873 | 2,476 | 71 | 2.07 | $452,003 | $168,576 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Return visit (30+ min) | 175 | $29,033 | $107 |
| Critical care, first 30-74 minutes | 85 | $28,051 | $180 |
| Short return visit (20+ min) | 167 | $16,409 | $76 |
| New patient visit (45+ min) | 60 | $7,958 | $133 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 42 | $5,474 | $101 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 49 | $4,946 | $69 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $4,788 | $150 |
| New patient visit (30+ min) | 51 | $4,029 | $79 |
| Test to measure expiratory airflow and volume | 116 | $3,028 | $24 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 38 | $2,987 | $77 |
| New patient visit (60+ min) | 13 | $2,608 | $201 |
| Test for exercise-induced lung stress | 37 | $1,270 | $30 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 42 | $1,249 | $29 |
| Evaluation of use of breathing device | 28 | $425 | $15 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 18 | $188 | $10 |
2022: 17 services
| Return visit (30+ min) | 182 | $29,802 | $107 |
| Critical care, first 30-74 minutes | 77 | $26,223 | $183 |
| Short return visit (20+ min) | 140 | $13,465 | $78 |
| New patient visit (45+ min) | 104 | $13,026 | $125 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $7,499 | $167 |
| Test to examine how well the lungs exchange gases | 129 | $6,531 | $50 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 60 | $5,180 | $61 |
| Long return visit (40+ min) | 28 | $4,697 | $152 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $4,373 | $87 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 115 | $3,701 | $32 |
| New patient visit (60+ min) | 20 | $3,700 | $185 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 29 | $2,724 | $83 |
| New patient visit (30+ min) | 34 | $2,604 | $77 |
| Test to measure expiratory airflow and volume | 75 | $2,054 | $23 |
| Test for exercise-induced lung stress | 26 | $732 | $27 |
| Evaluation of use of breathing device | 23 | $336 | $13 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 17 | $201 | $11 |
2021: 19 services
| Critical care, first 30-74 minutes | 122 | $51,314 | $187 |
| Return visit (30+ min) | 153 | $27,092 | $111 |
| New patient visit (45+ min) | 123 | $16,029 | $130 |
| Short return visit (20+ min) | 87 | $8,450 | $77 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 70 | $6,931 | $60 |
| Test to examine how well the lungs exchange gases | 108 | $6,323 | $57 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $5,863 | $172 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 47 | $5,085 | $86 |
| Test to determine lung volumes using sensors | 65 | $3,205 | $49 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 80 | $3,192 | $40 |
| Long return visit (40+ min) | 15 | $2,281 | $152 |
| Test to measure expiratory airflow and volume | 68 | $1,955 | $28 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 25 | $1,933 | $72 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 15 | $1,749 | $97 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 12 | $1,429 | $119 |
| Critical care, each additional 30 minutes | 14 | $1,314 | $94 |
| Insertion of artery tube for blood sampling or infusion through skin | 17 | $676 | $38 |
| Test for exercise-induced lung stress | 14 | $395 | $28 |
| Evaluation of use of breathing device | 13 | $216 | $17 |
2020: 20 services
| Critical care, first 30-74 minutes | 98 | $36,624 | $182 |
| Return visit (30+ min) | 219 | $16,834 | $69 |
| New patient visit (45+ min) | 94 | $12,496 | $133 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 114 | $11,834 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 52 | $7,708 | $148 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 58 | $7,300 | $83 |
| Test to examine how well the lungs exchange gases | 81 | $3,517 | $43 |
| New patient visit (60+ min) | 15 | $2,734 | $182 |
| Test to determine lung volumes using sensors | 53 | $2,360 | $45 |
| Test to measure expiratory airflow and volume | 97 | $2,263 | $23 |
| Short return visit (20+ min) | 42 | $2,243 | $53 |
| Sleep study in sleep lab (6 years or older) | 29 | $2,217 | $76 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 30 | $1,605 | $54 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,523 | $117 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 17 | $1,381 | $77 |
| Sleep study including heart rate, breathing, and sleep time | 11 | $1,044 | $95 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 13 | $858 | $66 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 16 | $680 | $30 |
| Test to measure the level of nitric oxide gas | 23 | $255 | $11 |
| Evaluation of use of breathing device | 13 | $126 | $10 |
2019: 28 services
| Return visit (30+ min) | 343 | $34,070 | $73 |
| Critical care, first 30-74 minutes | 90 | $26,518 | $173 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 93 | $11,642 | $57 |
| New patient visit (45+ min) | 93 | $10,671 | $115 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 52 | $8,173 | $157 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 60 | $8,161 | $81 |
| Test to examine how well the lungs exchange gases | 119 | $5,267 | $39 |
| Test to measure expiratory airflow and volume | 166 | $5,185 | $25 |
| Short return visit (20+ min) | 68 | $3,877 | $50 |
| Sleep study including heart rate, breathing, and sleep time | 31 | $3,855 | $124 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 39 | $3,562 | $91 |
| Sleep study in sleep lab (6 years or older) | 36 | $3,494 | $94 |
| Test to determine lung volumes using sensors | 69 | $2,717 | $38 |
| New patient visit (60+ min) | 14 | $2,070 | $148 |
| Sleep study including heart rate, breathing, airflow, and effort | 15 | $1,530 | $102 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 33 | $1,417 | $43 |
| Long return visit (40+ min) | 13 | $1,305 | $93 |
| Critical care, each additional 30 minutes | 14 | $1,224 | $87 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 17 | $1,160 | $68 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 19 | $1,073 | $31 |
| Test to measure the level of nitric oxide gas | 66 | $987 | $14 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 16 | $763 | $48 |
| Influenza vaccine split virus, preservative free | 11 | $604 | $55 |
| Test for exercise-induced lung stress | 16 | $414 | $23 |
| Administration of influenza virus vaccine | 19 | $281 | $15 |
| Evaluation of use of breathing device | 22 | $269 | $12 |
| Ultrasonic guidance for blood vessel access | 13 | $148 | $11 |
| Test to examine how well the lungs exchange gases | 11 | $72 | $7 |
2018: 28 services
| Critical care, first 30-74 minutes | 159 | $44,910 | $174 |
| Return visit (30+ min) | 285 | $27,433 | $73 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 227 | $26,001 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 131 | $17,345 | $80 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 87 | $13,502 | $155 |
| New patient visit (45+ min) | 73 | $8,365 | $115 |
| Test to measure expiratory airflow and volume | 187 | $5,463 | $25 |
| Test to examine how well the lungs exchange gases | 112 | $4,664 | $38 |
| Short return visit (20+ min) | 79 | $4,070 | $49 |
| Test to determine lung volumes using sensors | 69 | $2,725 | $39 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 41 | $2,632 | $31 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 24 | $1,860 | $77 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 28 | $1,802 | $62 |
| Sleep study in sleep lab (6 years or older) | 18 | $1,623 | $90 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 14 | $1,584 | $113 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 14 | $1,341 | $96 |
| Long return visit (40+ min) | 13 | $1,266 | $97 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,238 | $103 |
| Critical care, each additional 30 minutes | 13 | $1,226 | $88 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 12 | $1,192 | $99 |
| Test to measure the level of nitric oxide gas | 49 | $755 | $13 |
| Influenza vaccine split virus, preservative free | 11 | $575 | $52 |
| Evaluation of use of breathing device | 29 | $350 | $12 |
| Administration of influenza virus vaccine | 16 | $305 | $19 |
| Test to determine lung volumes using sensors | 13 | $126 | $10 |
| Ultrasonic guidance for blood vessel access | 11 | $125 | $11 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 12 | $123 | $10 |
| Test to examine how well the lungs exchange gases | 14 | $101 | $7 |
2017: 31 services
| Critical care, first 30-74 minutes | 153 | $46,669 | $172 |
| Return visit (30+ min) | 310 | $34,741 | $72 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 215 | $20,119 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 121 | $15,271 | $80 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 88 | $13,798 | $155 |
| New patient visit (45+ min) | 79 | $8,871 | $112 |
| Sleep study in sleep lab (6 years or older) | 62 | $5,715 | $92 |
| Test to measure expiratory airflow and volume | 176 | $5,343 | $24 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 52 | $5,084 | $96 |
| Test to examine how well the lungs exchange gases | 110 | $4,376 | $37 |
| Sleep study including heart rate, breathing, airflow, and effort | 23 | $3,084 | $123 |
| Short return visit (20+ min) | 54 | $2,810 | $47 |
| Test to determine lung volumes using sensors | 69 | $2,635 | $38 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 26 | $2,492 | $96 |
| Long return visit (40+ min) | 20 | $2,067 | $94 |
| Critical care, each additional 30 minutes | 23 | $2,003 | $87 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 17 | $1,911 | $112 |
| New patient visit (60+ min) | 13 | $1,797 | $138 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 16 | $1,616 | $101 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 11 | $1,587 | $144 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 28 | $1,554 | $30 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,297 | $100 |
| Pulmonary exercise testing | 29 | $1,203 | $40 |
| Test to measure the level of nitric oxide gas | 65 | $937 | $13 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 16 | $561 | $35 |
| Evaluation of use of breathing device | 40 | $484 | $12 |
| Administration of influenza virus vaccine | 13 | $304 | $23 |
| Test to determine lung volumes using sensors | 17 | $164 | $10 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 15 | $152 | $10 |
| Test to examine how well the lungs exchange gases | 17 | $121 | $7 |
| Test to measure expiratory airflow and volume | 12 | $79 | $7 |
2016: 29 services
| Critical care, first 30-74 minutes | 165 | $45,511 | $171 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 252 | $25,403 | $55 |
| Return visit (30+ min) | 170 | $15,295 | $75 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 128 | $14,499 | $78 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 87 | $13,331 | $153 |
| Short return visit (20+ min) | 178 | $10,601 | $49 |
| New patient visit (45+ min) | 63 | $7,348 | $117 |
| Sleep study in sleep lab (6 years or older) | 58 | $5,476 | $94 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 42 | $4,149 | $96 |
| Test to examine how well the lungs exchange gases | 94 | $3,613 | $38 |
| Test to measure expiratory airflow and volume | 133 | $3,497 | $25 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 76 | $3,175 | $30 |
| Test to determine lung volumes using sensors | 72 | $2,779 | $38 |
| Long return visit (40+ min) | 24 | $2,561 | $102 |
| New patient visit (60+ min) | 16 | $2,442 | $153 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 24 | $2,285 | $95 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 12 | $1,764 | $147 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,714 | $101 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 16 | $1,643 | $103 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 23 | $1,532 | $67 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 11 | $1,037 | $86 |
| Pulmonary exercise testing | 24 | $965 | $40 |
| Test to measure the level of nitric oxide gas | 38 | $506 | $13 |
| Administration of influenza virus vaccine | 19 | $414 | $22 |
| Test to determine lung volumes using sensors | 32 | $306 | $10 |
| Test to examine how well the lungs exchange gases | 35 | $249 | $7 |
| Evaluation of use of breathing device | 17 | $235 | $12 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 20 | $212 | $10 |
| Test to measure expiratory airflow and volume | 17 | $111 | $7 |
2015: 32 services
| Critical care, first 30-74 minutes | 155 | $43,014 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 255 | $22,325 | $54 |
| Return visit (30+ min) | 162 | $15,314 | $74 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 98 | $15,032 | $150 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 97 | $12,221 | $79 |
| Short return visit (20+ min) | 182 | $10,647 | $50 |
| New patient visit (45+ min) | 64 | $7,470 | $117 |
| Sleep study in sleep lab (6 years or older) | 57 | $5,218 | $92 |
| Test to examine how well the lungs exchange gases | 111 | $4,351 | $39 |
| Test to measure expiratory airflow and volume | 156 | $4,307 | $25 |
| New patient visit (60+ min) | 28 | $4,215 | $151 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 40 | $3,900 | $97 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 38 | $3,552 | $93 |
| Pneumococcal vaccine, 13-valent | 21 | $3,488 | $166 |
| Test to determine lung volumes using sensors | 93 | $3,446 | $37 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 28 | $2,946 | $105 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 67 | $2,705 | $30 |
| Long return visit (40+ min) | 19 | $1,964 | $98 |
| Pulmonary exercise testing | 43 | $1,920 | $41 |
| Transitional care management services for problem of at least moderate complexity | 15 | $1,781 | $119 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 11 | $1,692 | $154 |
| Aspiration of initial secretion of lung airway using an endoscope | 13 | $1,578 | $121 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 16 | $1,341 | $84 |
| Critical care, each additional 30 minutes | 13 | $1,120 | $86 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 16 | $946 | $59 |
| Administration of pneumococcal vaccine | 21 | $530 | $23 |
| Evaluation of use of breathing device | 35 | $445 | $12 |
| Test to determine lung volumes using sensors | 34 | $316 | $9 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 31 | $303 | $10 |
| Test to examine how well the lungs exchange gases | 35 | $242 | $7 |
| Test to measure the level of nitric oxide gas | 14 | $195 | $14 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 15 | $172 | $11 |
2014: 32 services
| Critical care, first 30-74 minutes | 126 | $34,916 | $168 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 218 | $21,420 | $54 |
| Return visit (30+ min) | 177 | $16,788 | $76 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 111 | $15,752 | $78 |
| Short return visit (20+ min) | 209 | $13,480 | $50 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 72 | $11,230 | $154 |
| New patient visit (45+ min) | 95 | $10,982 | $116 |
| Test to examine how well the lungs exchange gases | 150 | $5,674 | $37 |
| Test to measure expiratory airflow and volume | 178 | $5,009 | $25 |
| Test to determine lung volumes using sensors | 124 | $4,484 | $36 |
| Long return visit (40+ min) | 33 | $3,621 | $103 |
| Sleep study in sleep lab (6 years or older) | 38 | $3,591 | $94 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 78 | $3,521 | $30 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 32 | $3,146 | $98 |
| New patient visit (60+ min) | 23 | $3,094 | $135 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,209 | $105 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 22 | $2,109 | $96 |
| Pneumococcal vaccine, 13-valent | 14 | $2,086 | $149 |
| Pulmonary exercise testing | 35 | $1,589 | $40 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 18 | $1,523 | $85 |
| Diagnostic exam of voice box using a flexible endoscope | 13 | $1,105 | $85 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 18 | $938 | $49 |
| Hospital discharge day management, 30 minutes or less | 13 | $714 | $55 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 16 | $498 | $31 |
| Administration of influenza virus vaccine | 21 | $454 | $22 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 32 | $414 | $10 |
| Administration of pneumococcal vaccine | 17 | $409 | $23 |
| Evaluation of use of breathing device | 25 | $327 | $12 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 21 | $313 | $15 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 18 | $172 | $10 |
| Test to determine lung volumes using sensors | 13 | $125 | $10 |
| Test to examine how well the lungs exchange gases | 16 | $114 | $7 |
2013: 33 services
| Critical care, first 30-74 minutes | 104 | $24,504 | $166 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 120 | $18,235 | $148 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 184 | $17,090 | $54 |
| Return visit (30+ min) | 160 | $14,814 | $74 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 96 | $12,411 | $77 |
| Short return visit (20+ min) | 160 | $9,774 | $51 |
| New patient visit (45+ min) | 69 | $7,886 | $114 |
| Sleep study in sleep lab (6 years or older) | 73 | $6,659 | $90 |
| Test to examine how well the lungs exchange gases | 132 | $5,908 | $44 |
| Test to determine lung volumes using sensors | 117 | $5,023 | $43 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 54 | $5,020 | $93 |
| Pneumococcal vaccine, 13-valent | 29 | $4,101 | $141 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 96 | $3,696 | $29 |
| Test to measure expiratory airflow and volume | 116 | $3,207 | $26 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $2,975 | $103 |
| New patient visit (60+ min) | 18 | $2,745 | $152 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 26 | $2,418 | $93 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 34 | $2,064 | $59 |
| Pulmonary exercise testing | 38 | $1,854 | $42 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 41 | $1,827 | $45 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 12 | $1,802 | $150 |
| Hospital discharge day management, 30 minutes or less | 27 | $1,452 | $54 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 17 | $1,438 | $80 |
| Long return visit (40+ min) | 13 | $1,117 | $86 |
| Administration of pneumococcal vaccine | 36 | $844 | $23 |
| Administration of influenza virus vaccine | 20 | $467 | $23 |
| Evaluation of use of breathing device | 27 | $344 | $13 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 26 | $295 | $11 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 20 | $270 | $13 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 21 | $208 | $10 |
| Test to examine how well the lungs exchange gases | 25 | $181 | $7 |
| Exam of lung airways using an endoscope | 11 | $119 | $8 |
| Test to determine lung volumes using sensors | 12 | $118 | $10 |
Medicaid work
$12,462 in 2024
Medicaid paid $12,462 for 353 billed services this clinician did in 2024, up to 39 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 194 | $5,966 |
| Return visit (30+ min) | 77 | $3,495 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 82 | $3,001 |
| 2024 | 353 | 3 | 39 | $12,462 |
| 2023 | 685 | 6 | 40 | $29,930 |
| 2022 | 435 | 6 | 25 | $28,597 |
| 2021 | 521 | 9 | 30 | $31,764 |
| 2020 | 412 | 13 | 19 | $15,858 |
| 2019 | 232 | 4 | 16 | $846 |
| 2018 | 414 | 8 | 18 | $5,055 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 265 | $11,131 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 162 | $5,577 |
| Short return visit (20+ min) | 167 | $5,112 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 28 | $4,083 |
| EVALUATION OF WHEEZING | 40 | $2,451 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 23 | $1,576 |
2022
| Return visit (30+ min) | 133 | $6,652 |
| Diffusing capacity | 85 | $6,298 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 45 | $5,547 |
| EVALUATION OF WHEEZING | 65 | $4,434 |
| New patient visit (45+ min) | 28 | $3,296 |
| Short return visit (20+ min) | 79 | $2,371 |
2021
| Return visit (30+ min) | 192 | $7,870 |
| New patient visit (45+ min) | 71 | $6,465 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 40 | $5,249 |
| Diffusing capacity | 72 | $4,120 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 48 | $3,246 |
| EVALUATION OF WHEEZING | 46 | $2,888 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 25 | $886 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 15 | $552 |
| Short return visit (20+ min) | 12 | $488 |
2020
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 38 | $5,436 |
| New patient visit (45+ min) | 54 | $3,733 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 123 | $1,626 |
| Return visit (30+ min) | 55 | $1,605 |
| Diffusing capacity | 19 | $1,339 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 17 | $1,116 |
| EVALUATION OF WHEEZING | 14 | $951 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 13 | $51 |
| TOBACCO NON-USER | 20 | $0 |
| SPIROM DOC REV | 14 | $0 |
| Flu immunize order/admin | 19 | $0 |
| Spirometry results documented (fev1/fvc < 70%) | 13 | $0 |
2019
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 15 | $430 |
| Return visit (30+ min) | 53 | $370 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 12 | $46 |
| SPIROM DOC REV | 152 | $0 |
2018
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 38 | $2,235 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 98 | $1,441 |
| Return visit (30+ min) | 86 | $955 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 26 | $337 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 15 | $87 |
| SPIROM DOC REV | 115 | $0 |
| Spirometry results documented (fev1/fvc < 70%) | 19 | $0 |
| Long-acting inhaled bronchodilator prescribed | 17 | $0 |
Drugs they prescribed that Part D paid
$476,919
Pharmacies billed $476,919 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
578 generic and 1,100 brand-name prescriptions · $476,919 in drug cost · 60 antibiotic prescriptions to 30 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trelegy Ellipta | 194 | $135,358 | $698 |
| Breztri Aerosphere | 111 | $86,766 | $782 |
| Anoro Ellipta | 123 | $54,077 | $440 |
| Breo Ellipta | 94 | $43,680 | $465 |
| Spiriva Respimat | 43 | $26,991 | $628 |
See all 25 drugs
| Trelegy Ellipta | 194 | $135,358 | $698 |
| Breztri Aerosphere | 111 | $86,766 | $782 |
| Anoro Ellipta | 123 | $54,077 | $440 |
| Breo Ellipta | 94 | $43,680 | $465 |
| Spiriva Respimat | 43 | $26,991 | $628 |
| Incruse Ellipta | 52 | $22,880 | $440 |
| Arnuity Ellipta | 86 | $21,698 | $252 |
| Stiolto Respimat | 17 | $8,941 | $526 |
| Albuterol Sulfate Hfa | 247 | $8,345 | $34 |
| Symbicort | 21 | $7,505 | $357 |
| Spiriva Handihaler | 12 | $6,191 | $516 |
| Breyna | 27 | $6,148 | $228 |
| Dulera | 16 | $6,113 | $382 |
| Qvar Redihaler | 14 | $4,234 | $302 |
| Ventolin Hfa | 70 | $3,852 | $55 |
| Advair Diskus | 15 | $2,816 | $188 |
| Fluconazole | 17 | $2,333 | $137 |
| Wixela Inhub | 39 | $1,769 | $45 |
| Montelukast | 108 | $1,025 | $9 |
| Fluticasone Propionate | 68 | $696 | $10 |
| Roflumilast | 12 | $672 | $56 |
| Prednisone | 86 | $284 | $3 |
| Azithromycin | 31 | $155 | $5 |
| Ropinirole | 30 | $148 | $5 |
| Doxycycline Hyclate | 11 | $125 | $11 |
Year by year
| 2024 | 1,678 | 226 | None | 66% | $476,919 |
| 2023 | 1,387 | 190 | 0% (0) | 66% | $469,915 |
| 2022 | 1,180 | 157 | 0% (0) | 65% | $436,408 |
| 2021 | 878 | 177 | 0% (0) | 72% | $366,703 |
| 2020 | 1,769 | 239 | None | 68% | $758,658 |
| 2019 | 2,066 | 242 | 0% (0) | 65% | $1,017,939 |
| 2018 | 1,839 | 253 | 0% (0) | 64% | $949,335 |
| 2017 | 2,151 | 259 | None | 57% | $1,067,550 |
| 2016 | 1,960 | 259 | None | 60% | $1,034,569 |
| 2015 | 2,054 | 295 | 1% (13) | 57% | $797,657 |
| 2014 | 1,670 | 271 | 1% (11) | 57% | $482,655 |
| 2013 | 1,418 | 234 | None | 54% | $246,283 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Trelegy Ellipta | 149 | $112,605 | $756 |
| Breztri Aerosphere | 70 | $69,767 | $997 |
| Breo Ellipta | 119 | $55,628 | $467 |
| Spiriva Respimat | 57 | $34,285 | $601 |
| Incruse Ellipta | 55 | $33,640 | $612 |
| Symbicort | 47 | $25,655 | $546 |
| Anoro Ellipta | 49 | $23,799 | $486 |
| Arnuity Ellipta | 58 | $20,118 | $347 |
| Stiolto Respimat | 24 | $14,405 | $600 |
| Advair Diskus | 12 | $7,770 | $648 |
| Albuterol Sulfate Hfa | 172 | $7,043 | $41 |
| Qvar Redihaler | 13 | $5,144 | $396 |
| Modafinil | 11 | $4,950 | $450 |
| Ventolin Hfa | 72 | $4,679 | $65 |
| Wixela Inhub | 19 | $3,325 | $175 |
| Montelukast | 127 | $2,287 | $18 |
| Fluticasone Propionate | 51 | $957 | $19 |
| Tadalafil | 12 | $554 | $46 |
| Ethambutol | 13 | $479 | $37 |
| Prednisone | 83 | $345 | $4 |
| Azithromycin | 23 | $160 | $7 |
| Ropinirole | 25 | $51 | $2 |
2022: 20 drugs
| Trelegy Ellipta | 106 | $80,312 | $758 |
| Breztri Aerosphere | 77 | $60,404 | $784 |
| Spiriva Respimat | 61 | $34,137 | $560 |
| Symbicort | 62 | $28,572 | $461 |
| Breo Ellipta | 66 | $27,977 | $424 |
| Anoro Ellipta | 55 | $26,425 | $480 |
| Incruse Ellipta | 42 | $22,070 | $525 |
| Arnuity Ellipta | 54 | $14,316 | $265 |
| Stiolto Respimat | 15 | $7,369 | $491 |
| Fluticasone-Vilanterol | 17 | $6,704 | $394 |
| Albuterol Sulfate Hfa | 120 | $5,986 | $50 |
| Budesonide-Formoterol | 12 | $4,214 | $351 |
| Ventolin Hfa | 54 | $4,040 | $75 |
| Montelukast | 107 | $1,662 | $16 |
| Fluticasone Propionate | 40 | $638 | $16 |
| Tadalafil | 13 | $600 | $46 |
| Levalbuterol Tartrate Hfa | 11 | $594 | $54 |
| Prednisone | 84 | $399 | $5 |
| Famotidine | 11 | $166 | $15 |
| Ropinirole | 22 | $53 | $2 |
2021: 19 drugs
| Trelegy Ellipta | 73 | $54,018 | $740 |
| Anoro Ellipta | 70 | $35,282 | $504 |
| Breztri Aerosphere | 49 | $35,031 | $715 |
| Symbicort | 62 | $31,679 | $511 |
| Breo Ellipta | 62 | $28,275 | $456 |
| Spiriva Respimat | 35 | $19,578 | $559 |
| Arnuity Ellipta | 65 | $16,349 | $252 |
| Spiriva | 20 | $13,919 | $696 |
| Incruse Ellipta | 31 | $11,657 | $376 |
| Tadalafil | 11 | $7,729 | $703 |
| Stiolto Respimat | 11 | $5,158 | $469 |
| Albuterol Sulfate Hfa | 77 | $4,333 | $56 |
| Dulera | 12 | $3,898 | $325 |
| Ventolin Hfa | 26 | $1,856 | $71 |
| Montelukast | 86 | $1,335 | $16 |
| Fluticasone Propionate | 22 | $389 | $18 |
| Ropinirole | 15 | $270 | $18 |
| Prednisone | 43 | $265 | $6 |
| Azithromycin | 12 | $87 | $7 |
2020: 32 drugs
| Trelegy Ellipta | 181 | $124,211 | $686 |
| Breo Ellipta | 135 | $64,810 | $480 |
| Spiriva Respimat | 80 | $52,937 | $662 |
| Anoro Ellipta | 95 | $51,139 | $538 |
| Tadalafil | 21 | $44,647 | $2,126 |
| Symbicort | 90 | $38,617 | $429 |
| Spiriva | 63 | $32,338 | $513 |
| Incruse Ellipta | 51 | $23,063 | $452 |
| Arnuity Ellipta | 86 | $22,156 | $258 |
| Stiolto Respimat | 44 | $22,099 | $502 |
| Advair Diskus | 24 | $13,579 | $566 |
| Daliresp | 16 | $9,600 | $600 |
| Chantix | 12 | $8,945 | $745 |
| Wixela Inhub | 28 | $8,113 | $290 |
| Fluticasone-Salmeterol | 34 | $7,602 | $224 |
| Albuterol Sulfate Hfa | 113 | $7,197 | $64 |
| Ventolin Hfa | 70 | $4,595 | $66 |
| Flovent Hfa | 11 | $4,522 | $411 |
| Mometasone Furoate | 29 | $4,467 | $154 |
| Potassium Chloride | 19 | $2,328 | $123 |
| Montelukast | 122 | $1,417 | $12 |
| Proair Hfa | 15 | $1,361 | $91 |
| Sildenafil Citrate | 16 | $952 | $59 |
| Azelastine | 17 | $818 | $48 |
| Prednisone | 76 | $488 | $6 |
| Bupropion Hcl Sr | 14 | $482 | $34 |
| Fluticasone Propionate | 32 | $420 | $13 |
| Azithromycin | 22 | $335 | $15 |
| Ropinirole | 19 | $151 | $8 |
| Gabapentin | 22 | $126 | $6 |
| Zolpidem | 16 | $70 | $4 |
| Furosemide | 14 | $34 | $2 |
2019: 41 drugs
| Xyrem | 13 | $163,594 | $12,584 |
| Tadalafil | 34 | $83,410 | $2,453 |
| Trelegy Ellipta | 121 | $80,775 | $668 |
| Breo Ellipta | 144 | $69,004 | $479 |
| Spiriva | 109 | $57,594 | $528 |
| Symbicort | 99 | $46,348 | $468 |
| Advair Diskus | 66 | $42,247 | $640 |
| Spiriva Respimat | 58 | $38,645 | $666 |
| Anoro Ellipta | 69 | $35,450 | $514 |
| Orenitram Er | 14 | $29,228 | $2,088 |
| Incruse Ellipta | 46 | $21,998 | $478 |
| Arnuity Ellipta | 94 | $21,972 | $234 |
| Stiolto Respimat | 25 | $14,668 | $587 |
| Ventolin Hfa | 151 | $10,183 | $67 |
| Daliresp | 24 | $8,992 | $375 |
| Bevespi Aerosphere | 23 | $8,655 | $376 |
| Transderm-Scop | 12 | $7,541 | $628 |
| Wixela Inhub | 24 | $6,950 | $290 |
| Albuterol Sulfate Hfa | 80 | $5,363 | $67 |
| Vyvanse | 13 | $4,147 | $319 |
| Proair Hfa | 42 | $3,714 | $88 |
| Fluticasone-Salmeterol | 18 | $3,581 | $199 |
| Flovent Diskus | 13 | $3,206 | $247 |
| Mometasone Furoate | 28 | $2,996 | $107 |
| Potassium Chloride | 14 | $2,848 | $203 |
| Montelukast | 163 | $1,722 | $11 |
| Sildenafil Citrate | 15 | $910 | $61 |
| Xopenex Hfa | 11 | $761 | $69 |
| Modafinil | 12 | $747 | $62 |
| Bupropion Hcl Sr | 17 | $652 | $38 |
| Fluticasone Propionate | 53 | $635 | $12 |
| Prednisone | 112 | $552 | $5 |
| Azithromycin | 36 | $529 | $15 |
| Azelastine | 20 | $498 | $25 |
| Ropinirole | 20 | $465 | $23 |
| Gabapentin | 35 | $413 | $12 |
| Fluconazole | 14 | $289 | $21 |
| Methylphenidate | 13 | $283 | $22 |
| Doxycycline Hyclate | 12 | $142 | $12 |
| Amoxicillin | 14 | $69 | $5 |
| Furosemide | 12 | $42 | $4 |
2018: 31 drugs
| Adcirca | 50 | $206,548 | $4,131 |
| Xyrem | 12 | $139,842 | $11,653 |
| Letairis | 14 | $134,266 | $9,590 |
| Advair Diskus | 129 | $74,140 | $575 |
| Spiriva | 136 | $66,113 | $486 |
| Breo Ellipta | 130 | $58,046 | $447 |
| Tadalafil | 13 | $41,246 | $3,173 |
| Symbicort | 94 | $36,379 | $387 |
| Incruse Ellipta | 86 | $36,143 | $420 |
| Anoro Ellipta | 44 | $23,480 | $534 |
| Spiriva Respimat | 35 | $22,973 | $656 |
| Arnuity Ellipta | 66 | $15,099 | $229 |
| Ventolin Hfa | 156 | $11,767 | $75 |
| Stiolto Respimat | 20 | $10,048 | $502 |
| Bevespi Aerosphere | 18 | $6,554 | $364 |
| Proair Hfa | 60 | $4,871 | $81 |
| Mometasone Furoate | 29 | $4,266 | $147 |
| Vyvanse | 12 | $3,772 | $314 |
| Flovent Diskus | 15 | $3,635 | $242 |
| Montelukast | 204 | $2,135 | $10 |
| Bupropion Hcl Sr | 22 | $808 | $37 |
| Azithromycin | 41 | $500 | $12 |
| Warfarin | 25 | $437 | $17 |
| Fluticasone Propionate | 46 | $410 | $9 |
| Prednisone | 90 | $385 | $4 |
| Ropinirole | 16 | $181 | $11 |
| Omeprazole | 14 | $146 | $10 |
| Gabapentin | 18 | $132 | $7 |
| Pantoprazole | 19 | $113 | $6 |
| Famotidine | 20 | $66 | $3 |
| Clonazepam | 13 | $44 | $3 |
2017: 39 drugs
| Adcirca | 74 | $267,907 | $3,620 |
| Letairis | 19 | $176,369 | $9,283 |
| Xyrem | 12 | $129,414 | $10,784 |
| Advair Diskus | 146 | $76,001 | $521 |
| Spiriva | 149 | $71,903 | $483 |
| Symbicort | 139 | $47,720 | $343 |
| Breo Ellipta | 83 | $32,671 | $394 |
| Incruse Ellipta | 53 | $19,305 | $364 |
| Spiriva Respimat | 46 | $18,617 | $405 |
| Arnuity Ellipta | 60 | $10,956 | $183 |
| Combivent Respimat | 24 | $10,535 | $439 |
| Mometasone Furoate | 60 | $10,119 | $169 |
| Anoro Ellipta | 22 | $9,955 | $453 |
| Chantix | 12 | $7,237 | $603 |
| Daliresp | 12 | $7,126 | $594 |
| Proair Hfa | 83 | $5,273 | $64 |
| Ventolin Hfa | 76 | $4,922 | $65 |
| Stiolto Respimat | 13 | $4,478 | $344 |
| Flovent Diskus | 21 | $4,296 | $205 |
| Montelukast | 331 | $3,376 | $10 |
| Vyvanse | 12 | $3,255 | $271 |
| Asmanex | 12 | $3,142 | $262 |
| Xopenex Hfa | 17 | $1,188 | $70 |
| Prednisone | 155 | $912 | $6 |
| Theophylline | 14 | $577 | $41 |
| Fluticasone Propionate | 39 | $496 | $13 |
| Bupropion Hcl Sr | 12 | $426 | $36 |
| Warfarin | 34 | $411 | $12 |
| Azithromycin | 41 | $325 | $8 |
| Pantoprazole | 27 | $172 | $6 |
| Omeprazole | 16 | $153 | $10 |
| Ropinirole | 13 | $140 | $11 |
| Spironolactone | 11 | $134 | $12 |
| Amoxicillin | 16 | $105 | $7 |
| Gabapentin | 23 | $97 | $4 |
| Clonazepam | 14 | $93 | $7 |
| Zolpidem | 22 | $78 | $4 |
| Famotidine | 16 | $51 | $3 |
| Furosemide | 11 | $43 | $4 |
2016: 36 drugs
| Letairis | 37 | $319,941 | $8,647 |
| Adcirca | 86 | $259,379 | $3,016 |
| Advair Diskus | 153 | $75,978 | $497 |
| Spiriva | 169 | $73,114 | $433 |
| Symbicort | 144 | $48,846 | $339 |
| Breo Ellipta | 55 | $17,805 | $324 |
| Spiriva Respimat | 33 | $13,199 | $400 |
| Incruse Ellipta | 34 | $10,828 | $318 |
| Combivent Respimat | 26 | $10,526 | $405 |
| Advair Hfa | 15 | $9,366 | $624 |
| Daliresp | 24 | $8,224 | $343 |
| Asmanex | 37 | $7,583 | $205 |
| Transderm-Scop | 12 | $7,325 | $610 |
| Chantix | 11 | $5,887 | $535 |
| Ventolin Hfa | 68 | $5,619 | $83 |
| Flovent Diskus | 26 | $4,693 | $181 |
| Dulera | 12 | $4,408 | $367 |
| Qvar | 18 | $4,311 | $239 |
| Proair Hfa | 64 | $3,928 | $61 |
| Montelukast | 314 | $3,826 | $12 |
| Nasonex | 12 | $3,373 | $281 |
| Mometasone Furoate | 14 | $2,652 | $189 |
| Arnuity Ellipta | 15 | $2,255 | $150 |
| Xopenex Hfa | 20 | $1,399 | $70 |
| Prednisone | 116 | $678 | $6 |
| Azithromycin | 30 | $528 | $18 |
| Fluticasone Propionate | 38 | $398 | $10 |
| Warfarin | 43 | $310 | $7 |
| Omeprazole | 21 | $269 | $13 |
| Digoxin | 13 | $268 | $21 |
| Gabapentin | 22 | $181 | $8 |
| Fluconazole | 13 | $163 | $13 |
| Famotidine | 20 | $156 | $8 |
| Spironolactone | 14 | $148 | $11 |
| Amoxicillin | 25 | $131 | $5 |
| Pantoprazole | 20 | $118 | $6 |
2015: 34 drugs
| Letairis | 32 | $244,271 | $7,633 |
| Adcirca | 78 | $199,351 | $2,556 |
| Advair Diskus | 255 | $102,439 | $402 |
| Spiriva | 171 | $60,273 | $352 |
| Symbicort | 153 | $45,423 | $297 |
| Combivent Respimat | 43 | $14,739 | $343 |
| Daliresp | 33 | $10,247 | $311 |
| Proair Hfa | 140 | $9,030 | $64 |
| Asmanex | 39 | $6,682 | $171 |
| Transderm-Scop | 13 | $6,159 | $474 |
| Nasonex | 17 | $5,427 | $319 |
| Tudorza Pressair | 17 | $4,844 | $285 |
| Qvar | 22 | $3,766 | $171 |
| Breo Ellipta | 11 | $3,711 | $337 |
| Chantix | 14 | $3,706 | $265 |
| Montelukast | 304 | $3,664 | $12 |
| Dulera | 13 | $3,388 | $261 |
| Ventolin Hfa | 40 | $2,651 | $66 |
| Potassium Chloride | 23 | $840 | $37 |
| Fluticasone Propionate | 59 | $720 | $12 |
| Prednisone | 114 | $630 | $6 |
| Pantoprazole | 26 | $345 | $13 |
| Warfarin | 29 | $321 | $11 |
| Omeprazole | 19 | $295 | $16 |
| Digoxin | 17 | $262 | $15 |
| Fluconazole | 17 | $256 | $15 |
| Amoxicillin-Clavulanate Potass | 14 | $218 | $16 |
| Furosemide | 32 | $153 | $5 |
| Azithromycin | 20 | $150 | $7 |
| Gabapentin | 34 | $138 | $4 |
| Levofloxacin | 11 | $125 | $11 |
| Famotidine | 19 | $123 | $6 |
| Ciprofloxacin | 15 | $109 | $7 |
| Amoxicillin | 24 | $97 | $4 |
2014: 27 drugs
| Letairis | 22 | $157,272 | $7,149 |
| Adcirca | 38 | $80,432 | $2,117 |
| Advair Diskus | 217 | $80,396 | $370 |
| Spiriva | 152 | $49,326 | $325 |
| Symbicort | 146 | $38,855 | $266 |
| Combivent Respimat | 47 | $13,892 | $296 |
| Proair Hfa | 123 | $7,777 | $63 |
| Montelukast | 225 | $7,249 | $32 |
| Daliresp | 23 | $6,730 | $293 |
| Nasonex | 25 | $4,346 | $174 |
| Qvar | 28 | $4,189 | $150 |
| Ventolin Hfa | 23 | $1,581 | $69 |
| Ethambutol | 12 | $1,074 | $90 |
| Azithromycin | 39 | $1,010 | $26 |
| Fluticasone Propionate | 38 | $892 | $23 |
| Omeprazole | 24 | $843 | $35 |
| Prednisone | 95 | $567 | $6 |
| Potassium Chloride | 20 | $305 | $15 |
| Fluconazole | 16 | $220 | $14 |
| Bupropion Hcl Sr | 12 | $213 | $18 |
| Ciprofloxacin | 18 | $208 | $12 |
| Famotidine | 21 | $144 | $7 |
| Levofloxacin | 14 | $144 | $10 |
| Gabapentin | 25 | $139 | $6 |
| Warfarin | 23 | $136 | $6 |
| Pantoprazole | 16 | $119 | $7 |
| Furosemide | 26 | $103 | $4 |
2013: 25 drugs
| Advair Diskus | 205 | $69,053 | $337 |
| Spiriva | 133 | $43,937 | $330 |
| Adcirca | 16 | $27,486 | $1,718 |
| Symbicort | 58 | $18,257 | $315 |
| Combivent Respimat | 59 | $16,846 | $286 |
| Montelukast | 164 | $7,354 | $45 |
| Nasonex | 31 | $4,446 | $143 |
| Proair Hfa | 62 | $4,314 | $70 |
| Combivent | 16 | $4,261 | $266 |
| Asmanex | 17 | $2,859 | $168 |
| Ventolin Hfa | 45 | $2,006 | $45 |
| Dexilant | 12 | $1,777 | $148 |
| Fluticasone Propionate | 42 | $1,483 | $35 |
| Azithromycin | 29 | $704 | $24 |
| Potassium Chloride | 36 | $472 | $13 |
| Omeprazole | 16 | $386 | $24 |
| Bupropion Hcl Sr | 14 | $308 | $22 |
| Warfarin | 19 | $287 | $15 |
| Gabapentin | 23 | $275 | $12 |
| Prednisone | 78 | $260 | $3 |
| Famotidine | 22 | $188 | $9 |
| Klor-Con M10 | 12 | $154 | $13 |
| Ciprofloxacin | 18 | $139 | $8 |
| Fluconazole | 15 | $114 | $8 |
| Furosemide | 31 | $97 | $3 |
Money from drug and device companies
$23,063 in 2025
| 2025 | 18 | 82 | $20,560 | $23,063 |
| 2024 | 21 | 118 | $28,500 | $33,643 |
| 2023 | 18 | 100 | $16,150 | $18,887 |
| 2022 | 14 | 106 | $8,450 | $11,905 |
| 2021 | 14 | 65 | None | $1,181 |
| 2020 | 9 | 24 | None | $402 |
| 2019 | 16 | 48 | None | $2,486 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Breztri | $21,406 | 27 payments
|
| GlaxoSmithKline | Nucala | $311 | 13 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $303 | 8 payments
|
| Genzyme | Dupixent | $265 | 4 payments
|
| Inspire Medical Systems | Inspire | $200 | 3 payments
|
| Actelion Pharmaceuticals US | Uptravi | $159 | 6 payments
|
See all 78 published payments
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-12-18 | Jascayd | $23 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-12-17 | Ofev | $137 |
| GlaxoSmithKline | Meals · 2025-12-03 | Nucala | $4 |
| AstraZeneca Pharmaceuticals LP | Paid to speak or teach · 2025-11-27 | Breztri | $250 |
| AstraZeneca Pharmaceuticals LP | Paid to speak or teach · 2025-11-21 | Breztri | $1,020 |
| Verona Pharma | Meals · 2025-11-21 | Ohtuvayre | $19 |
| AstraZeneca Pharmaceuticals LP | Paid to speak or teach · 2025-11-20 | Breztri | $1,020 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-13 | Breztri | $17 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-13 | Breztri | $5 |
| AstraZeneca Pharmaceuticals LP | Paid to speak or teach · 2025-11-10 | Breztri | $1,020 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-05 | Airsupra | $12 |
| AstraZeneca Pharmaceuticals LP | Paid to speak or teach · 2025-11-03 | Breztri | $950 |
| AstraZeneca Pharmaceuticals LP | Paid to speak or teach · 2025-10-31 | Breztri | $700 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-10-23 | Jascayd | $18 |
| Actelion Pharmaceuticals US | Meals · 2025-10-08 | Opsynvi | $23 |
| AstraZeneca Pharmaceuticals LP | Paid to speak or teach · 2025-10-03 | Breztri | $1,850 |
| GlaxoSmithKline | Meals · 2025-10-02 | Nucala | $20 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-01 | Breztri | $117 |
| Mallinckrodt Hospital Products | Meals · 2025-09-27 | Acthar | $29 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-26 | Breztri | $24 |
| GlaxoSmithKline | Meals · 2025-09-24 | Nucala | $20 |
| AstraZeneca Pharmaceuticals LP | Paid to speak or teach · 2025-09-24 | Breztri | $700 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-09-18 | Ofev | $29 |
| AstraZeneca Pharmaceuticals LP | Paid to speak or teach · 2025-09-17 | Breztri | $2,800 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-11 | Breztri | $125 |
| AstraZeneca Pharmaceuticals LP | Paid to speak or teach · 2025-09-09 | Breztri | $2,800 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-03 | Breztri | $122 |
| GlaxoSmithKline | Meals · 2025-08-28 | Nucala | $19 |
| GlaxoSmithKline | Meals · 2025-08-25 | Trelegy Ellipta | $21 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-08 | Breztri | $27 |
| Verona Pharma | Meals · 2025-08-08 | Ohtuvayre | $16 |
| Inspire Medical Systems | Meals · 2025-08-07 | Inspire | $139 |
| Genzyme | Meals · 2025-08-06 | Dupixent | $115 |
| Inspire Medical Systems | Meals · 2025-08-01 | Inspire | $18 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-07-31 | Ofev | $26 |
| GlaxoSmithKline | Meals · 2025-07-24 | Trelegy Ellipta | $2 |
| GlaxoSmithKline | Meals · 2025-07-24 | Trelegy Ellipta | $13 |
| GlaxoSmithKline | Meals · 2025-07-15 | Nucala | $115 |
| AstraZeneca Pharmaceuticals LP | Paid to speak or teach · 2025-07-03 | Breztri | $950 |
| Genzyme | Meals · 2025-07-02 | Dupixent | $24 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-06-30 | Ofev | $22 |
| GlaxoSmithKline | Meals · 2025-06-27 | Nucala | $20 |
| Innovation Technologies | Meals · 2025-06-13 | Irrisept | $17 |
| Actelion Pharmaceuticals US | Meals · 2025-06-09 | Uptravi | $24 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-06-03 | Ofev | $23 |
| Genzyme | Meals · 2025-06-02 | Dupixent | $34 |
| AstraZeneca Pharmaceuticals LP | Paid to speak or teach · 2025-05-23 | Breztri | $2,800 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-21 | Breztri | $125 |
| GlaxoSmithKline | Meals · 2025-05-20 | Nucala | $16 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-12 | None | $14 |
| Philips North America | Meals · 2025-05-01 | Vest Therapy Und | $16 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-04-30 | Ofev | $24 |
| Bluewind Medical | Meals · 2025-04-30 | Revi | $34 |
| Actelion Pharmaceuticals US | Meals · 2025-04-28 | Uptravi | $33 |
| GlaxoSmithKline | Meals · 2025-04-22 | Nucala | $16 |
| Pulmonx | Meals · 2025-04-17 | Zephyr Delivery Catheter | $15 |
| CSL Behring | Meals · 2025-04-16 | Kcentra | $28 |
| Regeneron Healthcare Solutions | Meals · 2025-04-14 | Dupixent | $35 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-03 | None | $21 |
| Actelion Pharmaceuticals US | Meals · 2025-04-02 | Uptravi | $25 |
| Actelion Pharmaceuticals US | Meals · 2025-03-31 | Uptravi | $28 |
| Inspire Medical Systems | Meals · 2025-03-28 | Inspire | $43 |
| AstraZeneca Pharmaceuticals LP | Paid to speak or teach · 2025-03-26 | Breztri | $1,850 |
| Myriad Genetic Laboratories | Meals · 2025-03-24 | Prolaris | $23 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-19 | Breztri | $116 |
| United Therapeutics | Meals · 2025-03-18 | Tyvaso | $30 |
| Harmony Biosciences | Meals · 2025-03-13 | Wakix | $18 |
| Avadel CNS Pharmaceuticals | Meals · 2025-03-11 | Lumryz | $36 |
| AstraZeneca Pharmaceuticals LP | Paid to speak or teach · 2025-03-04 | Breztri | $1,850 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-27 | Breztri | $122 |
| GlaxoSmithKline | Meals · 2025-02-20 | Nucala | $23 |
| Genzyme | Meals · 2025-02-13 | Dupixent | $92 |
| Regeneron Healthcare Solutions | Meals · 2025-02-10 | Dupixent | $30 |
| Verona Pharma | Meals · 2025-02-10 | Ohtuvayre | $20 |
| GlaxoSmithKline | Meals · 2025-02-04 | Nucala | $23 |
| Actelion Pharmaceuticals US | Meals · 2025-01-23 | Opsumit | $27 |
| Regeneron Healthcare Solutions | Meals · 2025-01-07 | Dupixent | $31 |
| Myriad Genetic Laboratories | Meals · 2025-01-06 | Prolaris | $23 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $33,643
| AstraZeneca Pharmaceuticals LP | Breztri | $30,338 | 37 payments
|
| Medical Device Business Services | Monarch | $1,757 | 12 payments
|
| Inspire Medical Systems | Inspire | $206 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $188 | 8 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $185 | 7 payments
|
| United Therapeutics | Tyvaso | $178 | 9 payments
|
| Actelion Pharmaceuticals US | Uptravi | $165 | 8 payments
|
| Genzyme | Dupixent | $133 | 4 payments
|
| Regeneron Healthcare Solutions | Dupixent | $107 | 4 payments
|
| Insmed | Arikayce | $100 | 4 payments
|
| Amgen | Tezspire | $44 | 2 payments
|
| Electromed | Smartvest | $38 | 3 payments
|
| Pulmonx | Zephyr Delivery Catheter | $35 | 2 payments
|
| Ethicon US | Surgicel Nu-Knit | $32 | 1 payment
|
| Merck Sharp & Dohme | Winrevair | $27 | 1 payment
|
| CSL Behring | Kcentra | $25 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $18 | 1 payment
|
| Baxter Healthcare | Hillrom - Vest System Model 105 Home Care | $17 | 1 payment
|
| Boston Scientific | Lithovue | $17 | 1 payment
|
| Grifols USA | Prolastin-C Liquid | $17 | 1 payment
|
| Medtronic | Signia | $16 | 1 payment
|
2023: $18,887
| AstraZeneca Pharmaceuticals LP | Breztri | $16,952 | 20 payments
|
| GlaxoSmithKline | Nucala | $256 | 13 payments
|
| Actelion Pharmaceuticals US | Opsumit | $251 | 16 payments
|
| Myriad Genetic Laboratories | Prolaris | $248 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $211 | 9 payments
|
| Harmony Biosciences | Wakix | $161 | 8 payments
|
| Inspire Medical Systems | Inspire | $130 | 3 payments
|
| Ethicon | Monarch Platform | $122 | 2 payments
|
| United Therapeutics | Tyvaso | $118 | 4 payments
|
| Regeneron Healthcare Solutions | Dupixent | $106 | 4 payments
|
| Insmed | Arikayce | $84 | 4 payments
|
| Merck Sharp & Dohme | Belsomra | $66 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $65 | 4 payments
|
| Grifols USA | Prolastin-C Liquid | $41 | 2 payments
|
| Amgen | Tezspire | $23 | 1 payment
|
| Janssen Biotech | Rybrevant | $20 | 1 payment
|
| CSL Behring | Kcentra | $19 | 1 payment
|
| Hologic Sales and Service | Coolseal Generator | $14 | 1 payment
|
2022: $11,905
| AstraZeneca Pharmaceuticals LP | Breztri | $9,053 | 24 payments
|
| Ethicon | Monarch Platform | $1,198 | 11 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $473 | 16 payments
|
| Actelion Pharmaceuticals US | Opsumit | $289 | 15 payments
|
| Regeneron Healthcare Solutions | Dupixent | $221 | 8 payments
|
| Amgen | Tezspire | $174 | 4 payments
|
| United Therapeutics | Orenitram | $143 | 9 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $131 | 7 payments
|
| Grifols USA | Prolastin-C Liquid | $77 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $50 | 3 payments
|
| Gilead Sciences | Veklury | $32 | 2 payments
|
| Merck Sharp & Dohme | None | $24 | 1 payment
|
| Teva Pharmaceuticals USA | Airduo Digihaler | $20 | 1 payment
|
| Davol | Phasix Mesh | $20 | 1 payment
|
2021: $1,181
| GlaxoSmithKline | Trelegy Ellipta | $369 | 19 payments
|
| AstraZeneca Pharmaceuticals LP | Breztri | $299 | 16 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $125 | 5 payments
|
| Grifols USA | Prolastin-C Liquid | $120 | 7 payments
|
| Ethicon | Monarch Platform | $68 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $36 | 1 payment
|
| Genzyme | Dupixent | $35 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $34 | 2 payments
|
| Amgen | None | $22 | 1 payment
|
| Gilead Sciences | None | $17 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Aralast | $15 | 1 payment
|
| United Therapeutics | Orenitram | $15 | 1 payment
|
| Medtronic | Superdimension | $12 | 1 payment
|
| Electromed | Smartvest | $12 | 1 payment
|
2020: $402
| GlaxoSmithKline | Trelegy Ellipta | $137 | 9 payments
|
| AstraZeneca Pharmaceuticals LP | Symbicort | $98 | 6 payments
|
| Grifols USA | Prolastin-C Liquid | $47 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $30 | 1 payment
|
| Genzyme | Dupixent | $24 | 1 payment
|
| Insmed | Arikayce | $21 | 1 payment
|
| United Therapeutics | Orenitram | $16 | 1 payment
|
| Actelion Pharmaceuticals US | Uptravi | $16 | 1 payment
|
| Mylan Specialty L.P. | Yupelri | $15 | 1 payment
|
2019: $2,486
| Intuitive Surgical | Da Vinci Surgical System | $1,811 | 11 payments
|
| Insmed | Arikayce | $133 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spiriva Respimat | $82 | 5 payments
|
| GlaxoSmithKline | Anoro | $73 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Symbicort | $71 | 5 payments
|
| Grifols USA | Prolastin-C | $60 | 4 payments
|
| Mylan Specialty L.P. | Yupelri | $45 | 3 payments
|
| Mallinckrodt Enterprises | Acthar | $41 | 2 payments
|
| Shire North American Group | Glassia | $39 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $25 | 1 payment
|
| Ethicon | Monarch | $25 | 1 payment
|
| Sunovion Pharmaceuticals | Lonhala Magnair | $20 | 2 payments
|
| Daiichi Sankyo | Injectafer | $19 | 1 payment
|
| Genzyme | Lumizyme | $17 | 1 payment
|
| United Therapeutics | None | $15 | 1 payment
|
| Genentech USA | Xolair | $12 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Insmed, Inc. · Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study To Assess the Efficacy, Safety & Tolerability, and Pk of Ins1007 Administered Once Daily for 24 Weeks in Subjects With Non-Cf Bronchiectasis - the Willow Study · 2019 | Their institution | $2,500 |
Professional record
- NPI
- 1811963184
- Licence
- GA 056846
- Group
- Inpatient Specialists of California PC · Sutter Bay Medical Foundation
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- GA 336273219A
- Taxonomy
- Federal specialty code 207RP1001X (207RP1001X); Internal medicine (207R00000X); Federal specialty code 207RC0200X (207RC0200X); Federal specialty code 207RS0012X (207RS0012X)
- Mailing address
- 3320 Old Jefferson Rd, 200a, Athens, GA, 30607
- NPI first listed
- 2006-02-27
- NPI last updated
- 2014-09-18
This is when the NPI record was last certified, not a medical board exam.